An announcement from OncoCyte ( (OCX) ) is now available.
On March 4, 2025, Oncocyte Corporation’s Board of Directors approved salary increases for key executives, effective March 10, 2025, with Joshua Riggs, Andrea James, and Ekkehard Schüetz receiving raises. Additionally, Andrea James was awarded a $25,000 bonus for her contributions since June 2024. On March 9, 2025, the Board also approved substantial RSU grants for these executives, with vesting schedules tied to continued service. Furthermore, James Liu was promoted to Vice President Accounting, Controller, Treasurer, and Principal Accounting Officer, effective March 10, 2025, with a new salary and eligibility for bonuses and RSUs, reflecting his progression within the company since 2021.
More about OncoCyte
YTD Price Performance: 67.38%
Average Trading Volume: 77,618
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $82.14M
See more insights into OCX stock on TipRanks’ Stock Analysis page.